Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials

Ruben P. A. van Eijk(University Medical Center Utrecht), David J. Burn(Ollscoil na Gaillimhe – University of Galway), Gabriele Mora(University of Turin), Frank P. Diekstra(King's College London), Joanna Kelly(King's College London), Brian Dickie, Christopher Allen(Target (United States)), Ammar Al‐Chalabi(King's College London), John Zajicek(Peninsula College of Medicine and Dentistry), Esther Verstraete(University Medical Center Utrecht), Amanda Farrin, Jessica Mandrioli(University of Modena and Reggio Emilia), P. Nigel Leigh(University of Leeds), Marinus J.C. Eijkemans(Erasmus University Rotterdam), Christopher E. Shaw(King's College London), M Thornhill, Caroline Murphy(King's College London), Jan H. Veldink(University Medical Center Utrecht), Leonard H. van den Berg(University Medical Center Utrecht), Paolo Volanti(University of Siena), Wouter van Rheenen(King's College London), Aleksey Shatunov(University of Cambridge), Michael A. van Es(University Medical Center Utrecht), Gemma Reynolds(Middlesex University), R. W. Hornabrook, Carl Counsell, Giuseppe Borghero(University of Cagliari), Somendra Kumar Dhariwal, Pamela J. Shaw(University of Sheffield), Karen Morrison(University Hospitals Birmingham NHS Foundation Trust), Adriano Chiò(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), William Sproviero(King's College London), Carolyn Young(University of Liverpool), I Nick Steen, L. Savage, C. Payán, Justin S. Waters(Maidstone Hospital)
Neurology
October 5, 2017
Cited by 101


Related Papers